|
 Our skilled,
experienced staff measure behavioral endpoints quickly and accurately
to evaluate analgesic compounds and validate novel approaches.
Our team is capable of dosing test substances using a variety
of standard routes including intravenous, intraperitoneal, subcutaneous,
intramuscular, epidural, and oral. We are also prepared to dose compounds
directly to the CNS by intrathecal or intraventricular catheters
or pumps.
Each
model is validated with reference compounds (e.g., gabapentin, morphine
or others, as required by our partners). Careful monitoring
and observation ensures that gross motor or behavioral impairment
does not confound the interpretation of the behavioral endpoints.
Finally, we deliver raw and analyzed data with rigorous statistical
analysis for every project. A modular per-arm pricing approach
facilitates flexible experimental design to accommodate our
clients’ needs.
We work closely with our partners to design and execute flexible
pain research programs to facilitate critical decisions.
Some examples include:
Neuropathic Pain
• Nerve injury models (SNL, CCI, SCI)
• Diabetic polyneuropathy
• Chemotherapy-induced peripheral neuropathy
Chronic Pain
• MIA-induced osteoarthritis pain
• CFA-induced joint pain
• Rat model of bone cancer pain (MRMT)
Inflammatory Pain
• Formalin test
• Complete Freund’s Adjuvant (CFA)
• Carrageenan
• Capsaicin
Mechanical Trauma
• Plantar incision model of post-surgical pain (Brennan model)
Acute Pain
• Tail flick
• Hot plate test
Visceral Pain and Hypersensitivity
• Colorectal Distention Model (CRD) of IBS pain
• Interstitial Cystitis (IC) model of urinary bladder pain
• Post-operative ileus / gastric motility
Adverse Events
• Rotarod
• Irwin test
Coming soon, we are expanding our capabilities…
• PK/PD analysis in pathological state and more
• Compound solubility characterization
Please call for details
|